Replies to post #128210 on Biotech Values

[mcbio]

I think the royalty rate to AEZS starts from a high single digit and is progressing to
low double digit rate at higher sales.

That's correct (#msg-45885544). But I think AEZS still holds all perifosine rights outside of North America, other than Japan and Korea.